Gene Therapy    Rationale and design of Enhanced Angiogenic Cell Therapy in Acute Myocardial Infarction (ENACT-AMI): the first randomized placebo-controlled trial of enhanced progenitor cell therapy for acute myocardial infarction Am Heart J, 2010. 159(3): p. 354-60. M. Taljaard, et al., Gene transfer of inducible nitric oxide synthase affords cardioprotection by upregulating heme oxygenase-1 via a nuclear factor-{kappa}B-dependent pathway Circulation, 2009. 120(13): p. 1222-30. Q. Li, et al., Inhibition of prolyl hydroxylase domain proteins promotes therapeutic revascularization Circulation, 2009. 120(1): p. 50-9. C. Loinard, et al., Prevention of cardiac dysfunction in acute coxsackievirus B3 cardiomyopathy by inducible expression of a soluble coxsackievirus-adenovirus receptor Circulation, 2009. 120(23): p. 2358-66. S. Pinkert, et al., Myocardial adeno-associated virus serotype 6-betaARKct gene therapy improves cardiac function and normalizes the neurohormonal axis in chronic heart failure Circulation, 2009. 119(1): p. 89-98. G. Rengo, et al., Long-term cardiac-targeted RNA interference for the treatment of heart failure restores cardiac function and reduces pathological hypertrophy Circulation, 2009. 119(9): p. 1241-52. L. Suckau, et al., Hepatocyte growth factor or vascular endothelial growth factor gene transfer maximizes mesenchymal stem cell-based myocardial salvage after acute myocardial infarction Circulation, 2009. 120(11 Suppl): p. S247-54. T. Deuse, et al., Increased expression of integrin-linked kinase attenuates left ventricular remodeling and improves cardiac function after myocardial infarction Circulation, 2009. 120(9): p. 764-73. L. Ding, et al., Enhancement of myocardial regeneration through genetic engineering of cardiac progenitor cells expressing Pim-1 kinase Circulation, 2009. 120(21): p. 2077-87. K. M. Fischer, et al., Novel minicircle vector for gene therapy in murine myocardial infarction Circulation, 2009. 120(11 Suppl): p. S230-7. M. Huang, et al., Vascular endothelial growth factor-B induces myocardium-specific angiogenesis and arteriogenesis via vascular endothelial growth factor receptor-1- and neuropilin receptor-1-dependent mechanisms Circulation, 2009. 119(6): p. 845-56. J. E. Lahteenvuo, et al., Epicardial border zone overexpression of skeletal muscle sodium channel SkM1 normalizes activation, preserves conduction, and suppresses ventricular arrhythmia: an in silico, in vivo, in vitro study Circulation, 2009. 119(1): p. 19-27. D. H. Lau, et al.,